ArticleJournal of gastrointestinal oncology2024
Cancer metastasis to the upper gastrointestinal tract-a case series.
Article in Journal of gastrointestinal oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Recurrent Jejunal Melanoma Presenting as Obscure Gastrointestinal Bleeding: A Diagnostic Challenge.ACG case reports journal · 2026Article
- Potential metastatic mechanisms and clinical aspects in patients with non-gastrointestinal tumor metastasis to the upper gastrointestinal tract.Journal of gastrointestinal oncology · 2025Article
- Unmasking recurrent melena as the initial presentation of metastatic prostate cancer: a case report.Frontiers in oncology · 2025Article
- Primary lung cancer with duodenal metastasis complicated by obstructive jaundice and pancreatitis: a case report.Frontiers in oncology · 2025Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metastasis of non-gastrointestinal (non-GI) cancers to the upper GI tract is a rare occurrence, with limited cases reported in the literature. Recognising this type of metastasis is crucial, as it presents unique diagnostic and therapeutic challenges. This case series adds to the literature by discussing seven rare cases of non-GI cancer metastasising to the upper GI tract, emphasising the complications and clinical manifestations. These cases highlight the importance of early recognition and interdisciplinary management to optimise patient outcomes. Case Description: This retrospective series spans from 2016 to 2024 and includes seven consecutive patients from a tertiary hospital. The primary cancers include renal clear cell carcinoma, non-small cell lung cancer, prostate cancer, and melanoma. Each patient presented with unique patterns of metastasis to the GI tract, manifesting as complications such as upper GI bleeding, melaena, bowel perforation, abdominal pain and weight loss. Interventions ranged from gastroscopy and biopsy to surgical resection, and outcomes varied from disease control to progression with palliative interventions and fatality in some cases, despite targeted treatments. Follow-up of some of the cases highlights the difficulties in managing recurrent bleeding and perforation in these patients. Conclusions: Metastasis of non-GI primary tumours to the upper GI tract-although rare, requires clinicians to maintain a high index of suspicion when encountering unexplained GI symptoms in patients with a history of malignancy. This case series highlights the diverse presentations and complications of upper GI metastasis from non-GI cancers and underscores the need for personalised management strategies. Early recognition and tailored interventions can improve patient outcomes and reduce morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.